Patents · 2022 · pending
Treatment of HGFAC Related Diseases and Disorders
siRNA and antisense oligonucleotides targeting HGFAC, for cancer and related diseases.
- Filings
- 2
- Status
- Pending
- First priority
- Mar 16, 2022
Patents · 2022 · pending
siRNA and antisense oligonucleotides targeting HGFAC, for cancer and related diseases.